Across nearly 95,000 lives quietly tracked by wrist-worn devices, researchers have found that the dreaming mind may be doing more than processing the day's memories — it may be guarding the body against dozens of chronic illnesses. The REM stage of sleep, long understood as the theater of vivid dreams, now appears associated with lower risk across 83 distinct diseases, from diabetes to cardiovascular conditions. This large-scale, real-world finding invites medicine to reconsider what it has long undervalued: that the hours we spend unconscious may be as consequential to our health as the hours
Large Study Links More REM Sleep to Lower Risk of 83 Chronic Diseases
Those who spend more time dreaming show lower risk for 83 chronic diseases
So we're talking about nearly 100,000 people and their wrist trackers. That's a genuinely large dataset. What made researchers decide to look at REM sleep specifically?
REM sleep has long been associated with cognitive function and emotional regulation in smaller studies. But this is the first time anyone's had the scale to ask whether it matters for preventing actual chronic disease across a population.
I want to be careful here though. Correlation and causation are different things. We know REM sleep is lower in people with 83 diseases. But does more REM sleep prevent those diseases, or do the diseases themselves suppress REM sleep?
That's the honest answer—we don't know yet. The study shows the association. It doesn't prove direction.
What about the wearable trackers themselves? How accurate are they at measuring REM sleep?
That's a real limitation. Wrist trackers estimate REM based on movement and heart rate patterns. They're not as precise as lab equipment that actually measures brain waves. So some of the signal could be noise.
True, but the fact that the pattern held across 95,000 people suggests it's not just measurement error. Something consistent is there.
If someone wanted to increase their REM sleep, what would they actually do?
That's where we hit a wall. We don't have strong evidence that people can deliberately increase REM sleep the way they can, say, increase total sleep duration.
And we don't know if increasing REM sleep would actually reduce disease risk. The correlation doesn't tell us that. It tells us they're linked in this dataset.
So what's the next step for researchers?
Understanding the mechanism. Why would REM sleep protect against disease? And then, can you intervene on that mechanism?
And ideally, a prospective study where you follow people forward in time, not backward through their tracker data. That would help establish whether REM sleep changes actually lead to health changes.
Le Pouls
- A dataset of nearly 95,000 wearable-device users has revealed that people with more REM sleep face lower risk for 83 chronic diseases — a breadth of association that is difficult to dismiss as coincidence.
- The finding disrupts decades of clinical habit that placed diet and exercise at the center of disease prevention while treating sleep as a secondary concern.
- Because the data comes from real-world wrist trackers rather than controlled labs, it carries an ecological validity that traditional sleep studies rarely achieve — but also inherits the accuracy limitations of consumer-grade devices.
- Researchers and clinicians are now navigating the gap between correlation and causation: whether people can deliberately increase REM sleep, and whether doing so would actually reduce disease risk, remains unresolved.
- The study is accelerating momentum toward personalized sleep optimization as a legitimate clinical tool, potentially reshaping how doctors counsel patients on long-term health maintenance.
Across nearly 95,000 lives quietly tracked by wrist-worn devices, researchers have found that the dreaming mind may be doing more than processing the day's memories — it may be guarding the body against dozens of chronic illnesses. The REM stage of sleep, long understood as the theater of vivid dreams, now appears associated with lower risk across 83 distinct diseases, from diabetes to cardiovascular conditions. This large-scale, real-world finding invites medicine to reconsider what it has long undervalued: that the hours we spend unconscious may be as consequential to our health as the hours we spend choosing what to eat or how to move.
A study drawing on wrist-tracker data from nearly 95,000 people has found that greater time spent in REM sleep — the vivid, brain-active stage of the sleep cycle — is associated with meaningfully lower risk for 83 chronic diseases. The conditions span a wide range, including diabetes, cardiovascular disease, and metabolic disorders, suggesting that REM sleep may play a foundational role in how the body sustains health across multiple physiological systems rather than protecting against any single illness.
What distinguishes this research is its scale and its setting. Rather than observing small groups under laboratory conditions, scientists analyzed sleep as it actually unfolds in people's daily lives, captured passively by the devices millions already wear. That real-world grounding lends the findings a credibility that controlled studies, however precise, often struggle to claim.
The research lands at a moment when sleep science is pressing for equal standing alongside diet and exercise in preventive medicine. For years, clinical guidance treated sleep as secondary; this study adds considerable weight to the argument that sleep architecture — not just duration — deserves serious attention in health recommendations.
Important questions remain open. Consumer wrist trackers estimate REM sleep but cannot match the precision of laboratory measurement. Whether individuals can meaningfully extend their REM sleep through behavioral changes, and whether doing so would translate into reduced disease risk, is not yet established. Sleep is shaped by genetics, age, and environment in ways that resist easy intervention.
Still, the consistency of the association across 83 diseases points toward something real. The next phase of inquiry will focus on mechanism — understanding how REM sleep confers its apparent protection, and whether those pathways can be deliberately strengthened.
Researchers analyzing data from nearly 95,000 people wearing wrist trackers have found a striking correlation: those who spend more time in REM sleep—the stage when most vivid dreaming occurs—show lower risk for 83 different chronic diseases. The study represents one of the largest examinations of sleep architecture and disease prevention conducted through real-world wearable device data, moving beyond the controlled laboratory settings that have traditionally defined sleep research.
REM sleep, or rapid eye movement sleep, is the phase of the sleep cycle when the brain is most active, the eyes move quickly beneath closed lids, and dreams tend to be most intense and memorable. It typically accounts for about 20 to 25 percent of total sleep time in adults, though this varies considerably from person to person. The new research suggests that the amount of time individuals spend in this stage may serve as a meaningful marker for their vulnerability to a broad range of health conditions.
The diseases linked to lower REM sleep duration span multiple categories of chronic illness. Among them are diabetes, cardiovascular conditions, and various metabolic disorders—conditions that collectively affect millions of people and drive substantial healthcare costs. The breadth of the association is notable: rather than REM sleep protecting against a single disease or a narrow category of related conditions, the protective effect appears to extend across dozens of distinct chronic illnesses. This suggests that adequate REM sleep may play a foundational role in the body's ability to maintain health across multiple physiological systems.
What makes this research particularly significant is its scale and methodology. Rather than relying on small groups of volunteers in sleep laboratories, researchers drew on data collected passively by wearable devices—the wrist trackers that millions of people already wear daily. This approach captures sleep patterns as they actually occur in people's lives, without the artificial conditions of a lab setting. The 95,000 participants represent a genuine cross-section of the population using consumer sleep-tracking technology, lending the findings a real-world credibility that laboratory studies, however rigorous, cannot always achieve.
The findings arrive at a moment when sleep science is gaining recognition as central to preventive health. For years, medical guidance emphasized diet and exercise as the primary levers for disease prevention, with sleep often treated as secondary. This research adds weight to a growing body of evidence suggesting that sleep quality and architecture deserve equal standing in clinical recommendations. If the associations hold up under further scrutiny, they could reshape how doctors counsel patients about health maintenance and disease prevention.
The practical implications are still being worked out. Wearable trackers can estimate REM sleep, but they do so with varying degrees of accuracy—none can match the precision of laboratory polysomnography, which directly measures brain waves. The question of whether people can meaningfully increase their REM sleep through behavioral changes, and whether doing so would actually reduce disease risk in the way the correlations suggest, remains open. Sleep is influenced by genetics, age, circadian rhythms, and numerous environmental factors, many of which are difficult or impossible to modify.
Still, the sheer scale of the association—lower REM sleep linked to higher risk across 83 diseases—suggests something real is being measured. Whether that something is REM sleep itself, or whether REM sleep is a marker for some other aspect of sleep quality or overall health, will require additional investigation. The next phase of research will likely focus on understanding the mechanisms: how does REM sleep protect against disease, and can those protective pathways be strengthened through intervention.